Loading company…
New York biotechnology company developing therapies for neurodegenerative diseases, with a focus on Alzheimer's disease.
Founded in 2011 and headquartered in New York, US, Neurotrope develops therapies for neurodegenerative conditions, particularly Alzheimer's disease. Its CEO is Alan Tuchman. In October 2013 the company raised USD 1.08 million in Series A funding, which was its total raised at that point, and it reports a company valuation of USD 48.93 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in